Market Cap 597.83M
Revenue (ttm) 311.71M
Net Income (ttm) 163.06M
EPS (ttm) N/A
PE Ratio 3.97
Forward PE 13.96
Profit Margin 52.31%
Debt to Equity Ratio 0.00
Volume 2,033,400
Avg Vol 1,363,522
Day's Range N/A - N/A
Shares Out 77.94M
Stochastic %K 57%
Beta 1.50
Analysts Strong Sell
Price Target $14.00

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was in...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 517 9500
Address:
389 Interpace Pkwy, Suite 450, Parsippany, United States
hopedoesntGAF
hopedoesntGAF Aug. 19 at 10:49 AM
$CRMD It's interesting that peeps are still talking about a cliff after management raised full-year Adjusted EBITDA guidance to 125-140 Million range. After the call, insitutional analysts from companies like RBC hold private phone calls with Tedesco or investor relations with highly specific technical questions. While the exact pricing cannot be divulged for the orders taken for the remainder of 2026 by the new LDO, the total vial count count is fair game, and in doing simple math, the analyst can get the answers that retail cannot. The institutional "smart money" has already sttess-tested and verified CorMedix's gross margins behind closed doors. This is why institutions sit at 70% ownership of shares. Long before the call, NDRs ( Non-Deal-Roadshows) take place, private dinners or virtual conferences. Also Healthcare focused hedgefunds hire specialized,private medical research networks who interview LDO managers who confirm how fadt DefenCath is rolling out. EXTREMELY
1 · Reply
Derek22us
Derek22us Aug. 19 at 2:28 AM
$CRMD Be sure to keep us all up to speed on how the putz and call boys option diddling toxic, short enabling trash are pos itioned. Hoping that they end in the ben dover, with Hugh Jass syndrome and all expire worthless.
0 · Reply
CaliEmpress
CaliEmpress Aug. 19 at 2:08 AM
$CRMD Well yes 😉
0 · Reply
Noname2022
Noname2022 Aug. 18 at 11:19 PM
0 · Reply
CapitalMonk
CapitalMonk Aug. 18 at 11:16 PM
$CRMD Price: $8.17 (+6.52%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±5.46% RSI: 64.2 | Momentum: Strong Momentum Volume: +44.6% vs avg Volatility: 4.58% Support: $7.10 | Resistance: $8.98 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Linds_Erik
Linds_Erik Aug. 18 at 11:00 PM
$CRMD Noticed the close held the action above 8.30 after that 8.30 sell showed up to scare buyers. If it keeps clearing 8.30, it forces market makers to keep hedging long instead of leaning on put-side balance.
1 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 9:34 PM
$CRMD One last post... Tomorrow; The buying pressure we saw the last 2 days was in part sparked by the 8.00 puts, that btw are no longer In the money. MMs were forced to buy shares to remain neutral. I believe there is whale buying. The competition between institutions, MMs and scared shorts is what pushed us above 8. Shorts tried desperately to push this below 8, that failures was a huge win for longs. 👏 Tomorrow brings about the same problem for shorts, and MMs who will undoubtedly be eying the 8.50 calls. There are 3200 open 8.50 calls, the equivalent of 320k shares. And only 210 8.50 puts. 15-1 in favor of calls. MMs are happy right now, both 8.00 puts and 8.50 calls are out of the money. Tomorrow, shorts will throw big money at the open to try and reclaim sub 8. I doubt it works. There was a 7700 sell at 8.30 to scare buyers. It will reappear. If we get over 8.30, MMs will have to buy again. and compete with shorts for shares. 8.97 retest is possible.
4 · Reply
Jebus29
Jebus29 Aug. 18 at 9:18 PM
$CRMD I posted a couple days ago to say hi to everyone… Then we jumped 10% In short… Hello again. Lol
1 · Reply
TSLA_S3XY
TSLA_S3XY Aug. 18 at 8:25 PM
$CRMD Another Day Closer!
1 · Reply
hanovk68
hanovk68 Aug. 18 at 8:16 PM
$CRMD I firmly believe that CRMD’s current share price is being held down primarily by “uncertainty”. The uncertainty is a function of several future events including the following: what the final ESRD payment/regulatory requirements will be and it’s likely impact on DefenCath reimbursement; uncertainty relating to the future roll-out results of DefenCath by DaVita; uncertainty pertaining to the upcoming Rezzayo trial results and top line readout; uncertainty about whether CRMD will seek to acquire another smaller company; and uncertainty about Defen Cath receiving an expanded label for TPN. Many of these issues should be resolved in 2027 and as the uncertainty is resolved in a favorable manner, the share price will regain its positive momentum. Those who are patient should be handsomely rewarded.
1 · Reply
Latest News on CRMD
CorMedix reports Q2 EPS 29c vs. 28c last year

2026-08-17T07:58:32.000Z - 2 days ago

CorMedix reports Q2 EPS 29c vs. 28c last year


CorMedix Earnings Call Transcript: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

CorMedix Earnings Call Transcript: Q2 2026


CorMedix Earnings release: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

CorMedix Earnings release: Q2 2026


CorMedix Quarterly report: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

CorMedix Quarterly report: Q2 2026


CorMedix price target lowered to $13 from $14 at RBC Capital

2026-07-07T11:30:10.000Z - 6 weeks ago

CorMedix price target lowered to $13 from $14 at RBC Capital


CorMedix Transcript: AGM 2026

Jun 23, 2026, 9:00 AM EDT - 2 months ago

CorMedix Transcript: AGM 2026


CorMedix Slides: Corporate presentation

May 22, 2026, 7:00 AM EDT - 3 months ago

CorMedix Slides: Corporate presentation


CorMedix Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

CorMedix Earnings Call Transcript: Q1 2026


CorMedix Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

CorMedix Earnings release: Q1 2026


CorMedix Quarterly report: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

CorMedix Quarterly report: Q1 2026


CorMedix reports Q1 EPS 43c, consensus 33c

2026-05-14T11:53:51.000Z - 3 months ago

CorMedix reports Q1 EPS 43c, consensus 33c


CorMedix Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

CorMedix Proxy statement: Proxy filing


CorMedix Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

CorMedix Proxy statement: Proxy filing


CorMedix price target raised to $14 from $13 at RBC Capital

2026-04-28T11:56:23.000Z - 4 months ago

CorMedix price target raised to $14 from $13 at RBC Capital


CorMedix announces ReSPECT clinical trial met primary endpoint

2026-04-27T12:05:37.000Z - 4 months ago

CorMedix announces ReSPECT clinical trial met primary endpoint


CorMedix Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 4 months ago

CorMedix Proxy statement: Proxy filing


CorMedix Transcript: The Citizens Life Sciences Conference 2026

Mar 11, 2026, 9:35 AM EDT - 5 months ago

CorMedix Transcript: The Citizens Life Sciences Conference 2026


CorMedix Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 1:00 PM EDT - 5 months ago

CorMedix Transcript: Leerink Global Healthcare Conference 2026


CorMedix Slides: Corporate presentation

Mar 7, 2026, 6:00 AM EST - 5 months ago

CorMedix Slides: Corporate presentation


CorMedix price target lowered to $13 from $15 at Leerink

2026-03-06T17:05:52.000Z - 5 months ago

CorMedix price target lowered to $13 from $15 at Leerink


CorMedix Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

CorMedix Earnings Call Transcript: Q4 2025


CorMedix Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

CorMedix Annual report: Q4 2025


CorMedix Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

CorMedix Earnings release: Q4 2025


CorMedix reports Q4 EPS 16c vs 20c last year

2026-03-05T12:36:24.000Z - 5 months ago

CorMedix reports Q4 EPS 16c vs 20c last year


CorMedix to Participate in Upcoming Investor Conferences

Feb 12, 2026, 8:30 AM EST - 6 months ago

CorMedix to Participate in Upcoming Investor Conferences


CorMedix Transcript: Investor Day 2026

Feb 10, 2026, 1:00 PM EST - 6 months ago

CorMedix Transcript: Investor Day 2026


CorMedix Slides: FY 2026

Feb 10, 2026, 1:00 PM EST - 6 months ago

CorMedix Slides: FY 2026


CorMedix Therapeutics Announces Share Repurchase Program

Feb 2, 2026, 8:30 AM EST - 7 months ago

CorMedix Therapeutics Announces Share Repurchase Program


CorMedix price target lowered to $13 from $22 at RBC Capital

2026-01-21T11:35:46.000Z - 7 months ago

CorMedix price target lowered to $13 from $22 at RBC Capital


CorMedix Slides: Corporate presentation

Jan 10, 2026, 7:00 AM EST - 7 months ago

CorMedix Slides: Corporate presentation


CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:05 AM EST - 7 months ago

CorMedix Therapeutics Announces Leadership and Board Updates


CorMedix Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

CorMedix Earnings Call Transcript: Q3 2025


CorMedix Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

CorMedix Quarterly report: Q3 2025


CorMedix Earnings release: Q3 2025

Nov 12, 2025, 8:30 AM EST - 9 months ago

CorMedix Earnings release: Q3 2025


CorMedix Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 10 months ago

CorMedix Proxy statement: Proxy Filing


CorMedix Proxy statement: Proxy Filing

Oct 14, 2025, 8:00 AM EDT - 11 months ago

CorMedix Proxy statement: Proxy Filing


CorMedix Registration statement: Registration Filing

Sep 30, 2025, 8:00 AM EDT - 11 months ago

CorMedix Registration statement: Registration Filing


CorMedix Proxy statement: Proxy Filing

Sep 15, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing


CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 10:49 AM EDT - 1 year ago

CorMedix to Buy Melinta Therapeutics for $300 Million


CorMedix Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

CorMedix Quarterly report: Q2 2025


CorMedix Earnings release: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

CorMedix Earnings release: Q2 2025


CorMedix inc. Announces Customer Implementation

Jun 23, 2025, 7:30 AM EDT - 1 year ago

CorMedix inc. Announces Customer Implementation


CorMedix Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings Call Transcript: Q1 2025


CorMedix Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Quarterly report: Q1 2025


CorMedix Earnings release: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

CorMedix Earnings release: Q1 2025


CorMedix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing


CorMedix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

CorMedix Proxy statement: Proxy Filing


hopedoesntGAF
hopedoesntGAF Aug. 19 at 10:49 AM
$CRMD It's interesting that peeps are still talking about a cliff after management raised full-year Adjusted EBITDA guidance to 125-140 Million range. After the call, insitutional analysts from companies like RBC hold private phone calls with Tedesco or investor relations with highly specific technical questions. While the exact pricing cannot be divulged for the orders taken for the remainder of 2026 by the new LDO, the total vial count count is fair game, and in doing simple math, the analyst can get the answers that retail cannot. The institutional "smart money" has already sttess-tested and verified CorMedix's gross margins behind closed doors. This is why institutions sit at 70% ownership of shares. Long before the call, NDRs ( Non-Deal-Roadshows) take place, private dinners or virtual conferences. Also Healthcare focused hedgefunds hire specialized,private medical research networks who interview LDO managers who confirm how fadt DefenCath is rolling out. EXTREMELY
1 · Reply
Derek22us
Derek22us Aug. 19 at 2:28 AM
$CRMD Be sure to keep us all up to speed on how the putz and call boys option diddling toxic, short enabling trash are pos itioned. Hoping that they end in the ben dover, with Hugh Jass syndrome and all expire worthless.
0 · Reply
CaliEmpress
CaliEmpress Aug. 19 at 2:08 AM
$CRMD Well yes 😉
0 · Reply
Noname2022
Noname2022 Aug. 18 at 11:19 PM
0 · Reply
CapitalMonk
CapitalMonk Aug. 18 at 11:16 PM
$CRMD Price: $8.17 (+6.52%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±5.46% RSI: 64.2 | Momentum: Strong Momentum Volume: +44.6% vs avg Volatility: 4.58% Support: $7.10 | Resistance: $8.98 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Linds_Erik
Linds_Erik Aug. 18 at 11:00 PM
$CRMD Noticed the close held the action above 8.30 after that 8.30 sell showed up to scare buyers. If it keeps clearing 8.30, it forces market makers to keep hedging long instead of leaning on put-side balance.
1 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 9:34 PM
$CRMD One last post... Tomorrow; The buying pressure we saw the last 2 days was in part sparked by the 8.00 puts, that btw are no longer In the money. MMs were forced to buy shares to remain neutral. I believe there is whale buying. The competition between institutions, MMs and scared shorts is what pushed us above 8. Shorts tried desperately to push this below 8, that failures was a huge win for longs. 👏 Tomorrow brings about the same problem for shorts, and MMs who will undoubtedly be eying the 8.50 calls. There are 3200 open 8.50 calls, the equivalent of 320k shares. And only 210 8.50 puts. 15-1 in favor of calls. MMs are happy right now, both 8.00 puts and 8.50 calls are out of the money. Tomorrow, shorts will throw big money at the open to try and reclaim sub 8. I doubt it works. There was a 7700 sell at 8.30 to scare buyers. It will reappear. If we get over 8.30, MMs will have to buy again. and compete with shorts for shares. 8.97 retest is possible.
4 · Reply
Jebus29
Jebus29 Aug. 18 at 9:18 PM
$CRMD I posted a couple days ago to say hi to everyone… Then we jumped 10% In short… Hello again. Lol
1 · Reply
TSLA_S3XY
TSLA_S3XY Aug. 18 at 8:25 PM
$CRMD Another Day Closer!
1 · Reply
hanovk68
hanovk68 Aug. 18 at 8:16 PM
$CRMD I firmly believe that CRMD’s current share price is being held down primarily by “uncertainty”. The uncertainty is a function of several future events including the following: what the final ESRD payment/regulatory requirements will be and it’s likely impact on DefenCath reimbursement; uncertainty relating to the future roll-out results of DefenCath by DaVita; uncertainty pertaining to the upcoming Rezzayo trial results and top line readout; uncertainty about whether CRMD will seek to acquire another smaller company; and uncertainty about Defen Cath receiving an expanded label for TPN. Many of these issues should be resolved in 2027 and as the uncertainty is resolved in a favorable manner, the share price will regain its positive momentum. Those who are patient should be handsomely rewarded.
1 · Reply
Andy1063
Andy1063 Aug. 18 at 8:10 PM
$CRMD Very nice into the close!
0 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 7:50 PM
$CRMD Nasdaq down 350 points.... I guess today was a win.. nice relative strength 💪
0 · Reply
Stonehands
Stonehands Aug. 18 at 7:43 PM
$CRMD @hopedoesntGAF I'm glad you are bullish, but may I suggest you switch to decaf?
1 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 7:25 PM
$CRMD Move gawdammit....
0 · Reply
Derek22us
Derek22us Aug. 18 at 7:07 PM
$CRMD 700 share assk dropping bassturd active. Crush the maggots.
0 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 6:37 PM
$CRMD POWER HOUR ❤️ ..... In 20 minutes.
1 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 6:24 PM
$CRMD 5$ haircu*t needs therapy....
0 · Reply
GardeningGirl
GardeningGirl Aug. 18 at 6:24 PM
2 · Reply
hopedoesntGAF
hopedoesntGAF Aug. 18 at 6:22 PM
$CRMD 200 ma @ 8.48.... LFG!
0 · Reply
5dollaHayaCut
5dollaHayaCut Aug. 18 at 5:57 PM
$CRMD this will selloff by EOD
1 · Reply
SweStonk
SweStonk Aug. 18 at 5:05 PM
$CRMD with our fundamentals this should be $30 @ share at least. This will be that sooner rather than later! No better place to park my money Enjoy the ride while it last 😉
2 · Reply
peapope
peapope Aug. 18 at 5:00 PM
$CRMD finally
0 · Reply